The clinical status of cadaveric renal transplant patients treated for 10 year with cyclosporine therapy

被引:9
作者
Ponticelli, C [1 ]
Aroldi, A [1 ]
Elli, A [1 ]
Montagnino, G [1 ]
Vegeto, A [1 ]
Tarantino, A [1 ]
机构
[1] Osped Maggiore, IRCCS, Div Nefrol & Dialisi, I-20122 Milan, Italy
关键词
chronic rejection; cyclosporine; nephrotoxicity; renal transplantation;
D O I
10.1034/j.1399-0012.1999.130408.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
In this paper we assessed the clinical status of 150 cadaveric renal transplant patients who received cyclosporine without interruption for 10 yr. The mean creatinine clearance was 59.2 +/- 15.71 at 1 yr and 55.6 +/- 24.91 mL/min at 10 yr (p = 0.039). Patients were subdivided into four quartiles according to the mean creatinine clearance at 1 yr. The 14 patients with the lowest quartile showed a significant decrease of creatinine clearance from the Ist to 10th year (from 31.5 +/- 5.83 to 24.8 +/- 14.00 mL/min; p = 0.038) while no difference between the mean creatinine clearance at 1 and at 10 yr was found in the other three quartiles. At 10 yr, 84.6% patients needed antihypertensive therapy, a rate similar to that seen at 1 yr (81.4%). The mean plasma cholesterol (253 +/- 57.5 mg/dL) and triglyceride (197 +/- 113. 1 mg/dL) at 10 yr were similar to those found at 1 yr (243 +/- 48.2 and 201 +/- 143.0 mg/dL, respectively). Most patients have a high degree of rehabilitation 10 yr after uninterrupted cyclosporine therapy and all patients but 3 were able to work.
引用
收藏
页码:324 / 329
页数:6
相关论文
共 21 条
[1]   RENAL-TRANSPLANT FUNCTION AFTER 10 YEARS OF CYCLOSPORINE [J].
ALMOND, PS ;
GILLINGHAM, KJ ;
SIBLEY, R ;
MOSS, A ;
MELIN, M ;
LEVENTHAL, J ;
MANIVEL, C ;
KYRIAKIDES, P ;
PAYNE, WD ;
DUNN, DL ;
SUTHERLAND, DER ;
GORES, PF ;
NAJARIAN, JS ;
MATAS, AJ .
TRANSPLANTATION, 1992, 53 (02) :316-323
[2]   The risk of skin cancer in renal transplant recipients in Queensland, Australia [J].
Bavinck, JNB ;
Hardie, DR ;
Green, A ;
Cutmore, S ;
MacNaught, A ;
OSullivan, B ;
Siskind, V ;
VanDerWoude, FJ ;
Hardie, IR .
TRANSPLANTATION, 1996, 61 (05) :715-721
[3]   Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].
Bennett, WM ;
DeMattos, A ;
Meyer, MM ;
Andoh, T ;
Barry, JM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100
[4]  
BRUNNER FP, 1979, P EUR DIAL TRANSPLAN, V16, P2
[5]   LONG-TERM EFFICACY AND SAFETY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS [J].
BURKE, JF ;
PIRSCH, JD ;
RAMOS, EL ;
SALOMON, DR ;
STABLEIN, DM ;
VANBUREN, DH ;
WEST, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (06) :358-363
[6]  
CECKA JM, 1994, CLIN TRANSPLANT, V8, P324
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]  
CURTIS JJ, 1988, AM J MED, V85, P134
[9]  
Hollander AAMJ, 1997, J AM SOC NEPHROL, V8, P294
[10]  
KASISKE BL, 1997, KIDNEY INT, V63, P71